NFA
RGLS

Nationwide Fund Advisors’s Regulus Therapeutics RGLS Stock Holding History

Nationwide Fund Advisors’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-169
Closed -$33K – 3247
2017
Q1 		$33K Sell
169
-39
-19% -$7.42K ﹤0.01% 3039
2016
Q4 		$56K Hold
208
– – ﹤0.01% 2995
2016
Q3 		$82K Hold
208
– – ﹤0.01% 2952
2016
Q2 		$72K Sell
208
-250
-55% -$179K ﹤0.01% 3017
2016
Q1 		$381K Buy
458
+8
+2% +$6.37K ﹤0.01% 2231
2015
Q4 		$471K Buy
450
+298
+196% +$299K ﹤0.01% 2148
2015
Q3 		$120K Hold
152
– – ﹤0.01% 2824
2015
Q2 		$201K Buy
152
+59
+63% +$95.2K ﹤0.01% 2708
2015
Q1 		$189K Sell
93
-3
-3% -$6.52K ﹤0.01% 2718
2014
Q4 		$185K Buy
96
+8
+9% +$14.2K ﹤0.01% 2674
2014
Q3 		$72K Buy
88
+3
+4% +$2.54K ﹤0.01% 3059
2014
Q2 		$82K Buy
85
+18
+27% +$15.4K ﹤0.01% 3055
2014
Q1 		$72K Hold
67
– – ﹤0.01% 2819
2013
Q4 		$59K Hold
67
– – ﹤0.01% 3050
2013
Q3 		$76K Sell
67
-3
-4% -$3.54K ﹤0.01% 2997
2013
Q2 		$83K Buy
+70
New +$66.5K ﹤0.01% 2855

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nationwide Fund Advisors's RGLS Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Regulus Therapeutics (RGLS) in Q2 2017, closing a stake of 169 shares — an estimated $33K sold.

Nationwide Fund Advisors first reported a position in RGLS in Q2 2013 and held it in 16 quarters. The position peaked at $471K in Q4 2015. 46 funds tracked by Wall St. Rank hold RGLS as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Regulus Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 169 Regulus Therapeutics shares in Q2 2017, an estimated $33K.
  • Nationwide Fund Advisors first reported a position in Regulus Therapeutics in Q2 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Regulus Therapeutics position peaked at $471K in Q4 2015.
  • 46 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.